MedPath

The Effect of Time Restricted Eating on Glycemic and Proinflammatory Biomarkers Among Prediabetic Obese Jordanian Adults Aged 18-40 Years Old

Not Applicable
Not yet recruiting
Conditions
Insulin Resistance
Inflammation Biomarkers
Time Restricted Eating
Caloric Restriction
Obesity (Disorder)
Registration Number
NCT06911918
Lead Sponsor
University of Jordan
Brief Summary

Obesity, a global epidemic, significantly contributes to prediabetes, cardiovascular diseases, and other chronic diseases due to its pro-inflammatory nature. This studyl investigates the effects of time-restricted eating (TRE) with calorie restriction (CR), TRE without CR, and CR without TRE on glycemic control and pro-inflammatory biomarkers among prediabetic obese Jordanian adults aged 18-40 years. The study assesses changes in pro-inflammatory biomarkers (IL-1β, TNF-α, IL-6), insulin resistance (HOMA-IR), and body composition over 12 weeks.

Participants (n=120) will be randomized into four intervention arms: (1) TRE with CR, (2) TRE without CR, (3) CR without TRE, and (4) a control group with no dietary restrictions and no TRE. Biweekly anthropometric assessments will evaluate pro-inflammatory biomarkers and biochemical measures at baseline and the end of the study. The findings will provide insights into the comparative effectiveness of TRE and CR, potentially offering a safe, cost-effective intervention to prevent obesity-induced inflammation, prediabetes, and progression to type 2 diabetes mellitus.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  • IR individuals diagnosed with IR by the physicians as indicated by HOMA-IR score
  • female and male, BMI ≥ 30 to 39.9 kg/m2
  • age between 18 and 40 years
  • stable weight for 3 months before the beginning of the study
  • sedentary lifestyle
Exclusion Criteria
  • previous weight loss surgery
  • pregnancy or intent to become pregnant
  • breastfeeding
  • chronic diseases
  • drug therapies that could interfere with the effectiveness of the dietary intervention (e.g., use of corticosteroids, and anti-diabetic drugs)
  • diabetic type 1 and 2 individuals
  • anyone physically active to reduce the influence of confounding covariates

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Serum of TNF-α, IL-1β and IL-6baseline and after 12 weeks of intervention

Will be measured using ELISA before and after dietary intervention to assess the impact of time restricted eating on these proinflammatory biomarkers in participants diagnosed with Insulin resistance

Secondary Outcome Measures
NameTimeMethod
Homa-IRbaseline and after 12 weeks of intervention

Homa-IR will be assessed using the homeostasis model assessment (HOMA) method, which involves applying the formula \[fasting glucose (mg/dL) \* fasting insulin (mU/mL)/ 405\] to evaluate the changes in insulin resistance over 12 weeks of intervention

Lipid profile (LDL, HDL, TG, and cholesterol)baseline and after 12 weeks of intervention

will be analyzed at based line and post intervention to determine the impact of dietary modification on lipid profile

body weightbaseline and every 2 weeks until 12 weeks of intervention

in kilograms (Using inbody 120 )

Dietary intake using food recordsweek4, week 8, and week 12 week
Fasting blood glucosebaseline and after 12 weeks of intervention
fasting insulin levelbaseline and after 12 weeks of intervention
heightbaseline

in centimeters, Height measuring scale - Stadiometer without shoes

Body compositionbaseline and every 2 weeks until 12 weeks of intervention

%fat, fat in kilo grams, muscle mass in kilograms, using inbody 120

Trial Locations

Locations (1)

Najd Nutri Center

🇯🇴

Amman, Jordan

© Copyright 2025. All Rights Reserved by MedPath